OncoNano is a former spin-out from the UT Southwestern Medical Center, according to the Dallas Business Journal.
OncoNano Medicine, a Dallas-based biotech company, has raised $11.6 million from 27 private investors, according to SEC filing. The company is developing treatments for advanced ovarian cancer (with a Phase III trial) advanced breast cancer (Phase II and III trials) and Ewing’s Sarcoma, advanced non-small cell lung cancer, gynecological cancer, and advanced melanoma (Phase 1 trials), according to a report in D CEO Healthcare. Gradalis has not said how it intends to use the funding. has received $43.94 million of a $55 million equity funding offer, the company announced in a filing with the U.S. GRADALIS ANNOUNCES $43.94M EQUITY RAISEĭallas-based pharma company Gradalis Inc.
That will give Arkoma roughly 14-percent of Comstock’s outstanding shares.
#Stronghold resource partners series#
The investment was announced by Comstock as one of a series of related transactions bolstering its comprehensive refinancing of nearly all of the company’s existing debt.Īrkoma will buy 10 million shares of Comstock’s common stock at $7.50 per share, under the agreement. Dallas Cowboys owner Jerry Jones’ company Arkoma Drilling LP has agreed to make a $75 million equity investment in Frisco-based Comstock Resources Inc.
0 kommentar(er)
